Bioequivalence and Bioavailability Forum

Got it. [RSABE / ABEL]

posted by Helmut  – Vienna, Austria, 2012-10-23 18:23 (4586 d 11:22 ago) – Posting: # 9449
Views: 8,729

Dear Ben!

❝ I want to present the two approaches to non-statisticians: […] I believe the 95% upper limit approach could cause confusion...

Definitely. I’m familiar with confusion I regularly cause in my presentations. If you make clear that this is just an illustrative example – and not what the FDA actually requires – no problem.

—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! 
Helmut Schütz


The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

• Replicate Design: Scaling FDA Ben 2012-10-23 11:32 
  • Maybe – but why? Helmut 2012-10-23 15:35
    • Maybe – but why? Ben 2012-10-23 16:03
      • Got it.Helmut 2012-10-23 16:23
    • FDA Mixed up d_labes 2012-10-23 16:23
      • FDA Mixed up Helmut 2012-10-23 16:34
    • Maybe – but why? Ben 2012-10-27 17:04
      • Maybe – but why? Helmut 2012-10-27 17:57
        • Maybe – but why? Ben 2012-10-28 13:57
          • Potvin (and beyond?) Helmut 2012-10-28 15:59
            • Potvin (and beyond?) Ben 2012-11-01 10:17